CapsoVision, Inc. (CV)
NASDAQ
Closed
Aug 25, 2026
Day's Range
5.7952 wk Range
3.43Overview - CV - CapsoVision, Inc.
Key Statistics
Valuation
Enterprise Value
283.38M
P/E (Trailing)
‪-5.65‬
P/E (Forward)
‪-13.53‬
PEG Ratio
‪-0.36‬
Price / Sales (TTM)
‪21.00‬
Price / Book
‪22.16‬
EV / EBITDA
‪-9.58‬
Profitability
Gross Margin
‪47.60%‬
Profit Margin
‪-214.73%‬
Operating Margin
‪-208.07%‬
Return on Assets
‪-132.47%‬
Return on Equity
‪-335.06%‬
Ownership
Shares Outstanding
49.83M
Float
31.49M
Short % of Shares Outstanding
‪5.10%‬
Held by Insiders
‪32.03%‬
Held by Institutions
‪10.34%‬
Price stats
50-Day Avg
‪6.65‬
200-Day Avg
‪6.75‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CV - CapsoVision, Inc.
Peers - CV - CapsoVision, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - CV - CapsoVision, Inc.
About
CapsoVision, Inc. is a commercial-stage medical technology company specializing in advanced imaging and artificial intelligence technologies for endoscopy solutions. It focuses on identifying abnormalities in the gastrointestinal tract for diagnostic and screening purposes. The company's core product is the CapsoCam…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
